Brief: Immunome Presents Preclinical Data On Novel Anti-Epn1 Antibody Imm20059
07/11/2022 14:18
Nov 7 (Reuters) - Immunome Inc IMNM.O :
* IMMUNOME PRESENTS PRECLINICAL DATA ON NOVEL ANTI-EPN1
ANTIBODY
IMM20059 AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER’S (SITC)
37TH ANNUAL MEETING
Source text for Eikon: ID:nBw6zFQFSa
Further company coverage: IMNM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage